GSK will split into two new companies in 2022, they are GSK and Haleon. So what does this spin-off mean for Malaysia and the healthcare industry? Philip See speaks to Dr. Jonathan Pan, Vice President and GM of Malaysia and Brunei at GSK about their top-selling drugs, their role in the Covid-19 pandemic, and can Malaysia be a vaccine manufacturing hub?

MOF on Budget 2027: Subsidies, Goodies & Waad Nasional
34:48

Budget 2027: Pre-Election Goodies or Fiscal Discipline?
22:04

RT Pastry: IPO, Dividend Pause, & Kuantan Expansion
21:17